 Pitcairn Co. grew its holdings in shares of Regeneron Pharmaceuticals Inc NASDAQ:REGN by 4.8 in the second quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission SEC. The fund owned 672 shares of the biopharmaceutical companys stock after buying an additional 31 shares during the quarter. Pitcairn Co.s holdings ... 